ctrl K

Watchlist Price Alert

Oyster Point Pharma Inc. (OYST)

NASDAQ: OYST · Real-Time Price · USD

11.17

0.00 (0.00%)

At close: Dec 30, 2022, 9:00 PM

Oyster Point Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	24.54M	n/a	n/a	n/a	n/a
Cost of Revenue	1.52M	n/a	n/a	n/a	n/a
Gross Profit	23.01M	n/a	n/a	n/a	n/a
Operating Income	-96.92M	-70.99M	-47.3M	-16.74M	-5.68M
Interest Income	n/a	n/a	1.59M	233K	44K
Pretax Income	-100.66M	-70.52M	-45.71M	-16.5M	-6.6M
Net Income	-104.39M	-70.52M	-45.71M	-16.5M	-6.6M
Selling & General & Admin	95.44M	31.18M	13.67M	2.98M	2.05M
Research & Development	24.23M	39.81M	33.63M	13.76M	3.63M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	119.67M	70.99M	47.3M	16.74M	5.68M
Interest Expense	3.73M	n/a	n/a	n/a	488K
Selling & Marketing Expenses	54.62M	n/a	n/a	n/a	n/a
Cost & Expenses	121.19M	70.99M	47.3M	16.74M	5.68M
Income Tax Expense	3.73M	469K	1.59M	n/a	n/a
Shares Outstanding (Basic)	26.04M	24.13M	4.59M	9.02M	9.02M
Shares Outstanding (Diluted)	26.04M	24.13M	4.59M	9.02M	9.02M
EPS (Basic)	-4.01	-2.92	-9.97	-1.83	-0.73
EPS (Diluted)	-4.01	-2.92	-9.97	-1.83	-0.73
EBITDA	-96.78M	-70.06M	-45.69M	-16.5M	-6.11M
EBIT	n/a	n/a	n/a	n/a	-6.11M
Depreciation & Amortization	141K	461K	19K	233K	-430K